Who is sponsoring NCT03533309?

NCT03533309 is sponsored by Cairo University.

What drugs are being tested in NCT03533309?

Interventions in NCT03533309: Computer guided surgical cutting guide, Conventional alveolar ridge splitting.

What condition does NCT03533309 study?

NCT03533309 studies Ridge Deficency.

Is NCT03533309 still recruiting?

NCT03533309 is currently status unknown. Last updated 24 May 2018.

Last reviewed 2018-05-24 · How we verify

NCT03533309

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Accuracy of Computer Guided Versus Conventional Ridge Splitting of Horizontal Deficient in Maxillary Anterior Alveolar Ridge

Status unknown NA Last updated 24 May 2018

What this trial tests

NA trial testing Computer guided surgical cutting guide in Ridge Deficency in 14 participants. Status unknown.

Timeline

1 July 2018

Primary endpoint
30 July 2019

30 October 2019

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	double
Primary purpose	treatment
Enrollment	14
Start date	1 July 2018
Primary completion	30 July 2019
Estimated completion	30 October 2019

Drugs / interventions tested

Computer guided surgical cutting guide
Conventional alveolar ridge splitting

Conditions studied

Ridge Deficency — all drugs for Ridge Deficency →

Sponsor

Cairo University

Who can join

Adults 16 to 55, any sex, with Ridge Deficency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In patient with horizontal deficiency in alveolar ridge of the anterior maxilla, Dose computer Guided stent enhance the accuracy and clinical outcome vs conventional ridge splitting surgery????

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03533309 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 24 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03533309.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing